Weekly epirubicin in the treatment of gestational breast cancer (GBC)
- 20 August 2008
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 115 (3) , 591-594
Abstract
Background GBC is a rare disease and chemotherapy in this setting lacks a standardized approach. Patients and Methods Patients 16–30 weeks pregnant with locally advanced/metastatic disease or with high risk of recurrence after surgery were evaluated. Results Twenty patients received weekly epirubicin 35 mg/m2. Median maternal age was 37 years (23–42). Median gestational age at chemotherapy was 19 weeks. Thirteen patients were treated after surgery while 7 had locally advanced tumours of which one had liver metastases. Mean total epirubicin dose was 420 mg/m2 with a median number of 12 administrations (4–16). No grade 3–4 toxicities were observed. No foetal adverse events were observed except 1 premature delivery at 28 weeks. Births were induced by caesarean section in 12 patients at a median gestational age of 35 weeks. No malformations were reported except 1 newborn with polycystic kidney. At a median age of 2 years, neurological, cardiological and immunological development was normal in all children as reported by their parents. In 7/20 patients with evaluable disease, five had an objective response. At a median follow-up of 38 months, 17 patients are alive; 14 are disease free. Conclusions Weekly epirubicin appears safe and effective with low foetal toxicity and could be considered in GBC.Keywords
This publication has 22 references indexed in Scilit:
- Hormones and postpartum cardiomyopathyTrends in Endocrinology & Metabolism, 2007
- Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in uteroCancer, 2006
- Long-term evaluation of cardiac function in children who received anthracyclines during pregnancyAnnals of Oncology, 2005
- Chemotherapy for Breast Cancer During Pregnancy: An 18-Year Experience From Five London Teaching HospitalsJournal of Clinical Oncology, 2005
- Pregnancy and breast cancerBMJ, 2005
- Cardiovascular Complications of Cancer TherapyCirculation, 2004
- Fetal outcome after in utero exposure to cancer chemotherapyArchives of internal medicine (1960), 1992
- Delayed Childbearing and the Outcome of PregnancyNew England Journal of Medicine, 1990
- Pregnancy in association with a newly diagnosed cancer: A population‐based epidemiologic assessmentInternational Journal of Cancer, 1984
- Studies on β-Glucuronidase of the Developing Human PlacentaGynecologic and Obstetric Investigation, 1980